282 related articles for article (PubMed ID: 9066781)
1. Dramatic attenuation of hypusine formation on eukaryotic initiation factor 5A during senescence of IMR-90 human diploid fibroblasts.
Chen ZP; Chen KY
J Cell Physiol; 1997 Mar; 170(3):248-54. PubMed ID: 9066781
[TBL] [Abstract][Full Text] [Related]
2. Marked elevation of hypusine formation activity on eukaryotic initiation factor 5A in v-HA-RAS transformed mouse NIH3T3 cells.
Chen ZP; Chen KY
Cancer Lett; 1997 May; 115(2):235-41. PubMed ID: 9149130
[TBL] [Abstract][Full Text] [Related]
3. Hypusine: its post-translational formation in eukaryotic initiation factor 5A and its potential role in cellular regulation.
Park MH; Wolff EC; Folk JE
Biofactors; 1993 May; 4(2):95-104. PubMed ID: 8347280
[TBL] [Abstract][Full Text] [Related]
4. The role of hypusine depletion in cytostasis induced by S-adenosyl-L-methionine decarboxylase inhibition: new evidence provided by 1-methylspermidine and 1,12-dimethylspermine.
Byers TL; Lakanen JR; Coward JK; Pegg AE
Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):363-8. PubMed ID: 7980394
[TBL] [Abstract][Full Text] [Related]
5. The post-translational synthesis of a polyamine-derived amino acid, hypusine, in the eukaryotic translation initiation factor 5A (eIF5A).
Park MH
J Biochem; 2006 Feb; 139(2):161-9. PubMed ID: 16452303
[TBL] [Abstract][Full Text] [Related]
6. Enantiomers of 3-methylspermidine selectively modulate deoxyhypusine synthesis and reveal important determinants for spermidine transport.
Hyvönen MT; Khomutov M; Petit M; Weisell J; Kochetkov SN; Alhonen L; Vepsäläinen J; Khomutov AR; Keinänen TA
ACS Chem Biol; 2015 Jun; 10(6):1417-24. PubMed ID: 25689365
[TBL] [Abstract][Full Text] [Related]
7. Synergistic drug combination GC7/DFMO suppresses hypusine/spermidine-dependent eIF5A activation and induces apoptotic cell death in neuroblastoma.
Schultz CR; Geerts D; Mooney M; El-Khawaja R; Koster J; Bachmann AS
Biochem J; 2018 Jan; 475(2):531-545. PubMed ID: 29295892
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the activities of variant forms of eIF-4D. The requirement for hypusine or deoxyhypusine.
Park MH; Wolff EC; Smit-McBride Z; Hershey JW; Folk JE
J Biol Chem; 1991 May; 266(13):7988-94. PubMed ID: 1850732
[TBL] [Abstract][Full Text] [Related]
9. Posttranslational synthesis of hypusine: evolutionary progression and specificity of the hypusine modification.
Wolff EC; Kang KR; Kim YS; Park MH
Amino Acids; 2007 Aug; 33(2):341-50. PubMed ID: 17476569
[TBL] [Abstract][Full Text] [Related]
10. Higher activity of recombinant bovine deoxyhypusine synthase vs. human deoxyhypusine synthase.
Huang JK; Tsai S; Huang GH; Gowda PG; Walzer AM; Wen L
Protein Expr Purif; 2004 May; 35(1):32-8. PubMed ID: 15039063
[TBL] [Abstract][Full Text] [Related]
11. Deoxyhypusine synthase assay based on the use of polyhistidine-tagged substrate and metal chelate-affinity chromatography.
Tao Y; Skrenta HM; Chen KY
Anal Biochem; 1994 Aug; 221(1):103-8. PubMed ID: 7985780
[TBL] [Abstract][Full Text] [Related]
12. Interaction of eukaryotic initiation factor 5A with the human immunodeficiency virus type 1 Rev response element RNA and U6 snRNA requires deoxyhypusine or hypusine modification.
Liu YP; Nemeroff M; Yan YP; Chen KY
Biol Signals; 1997; 6(3):166-74. PubMed ID: 9285100
[TBL] [Abstract][Full Text] [Related]
13. Expression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapies.
Preukschas M; Hagel C; Schulte A; Weber K; Lamszus K; Sievert H; Pällmann N; Bokemeyer C; Hauber J; Braig M; Balabanov S
PLoS One; 2012; 7(8):e43468. PubMed ID: 22927971
[TBL] [Abstract][Full Text] [Related]
14. Structural features of the eIF-5A precursor required for posttranslational synthesis of deoxyhypusine.
Joe YA; Park MH
J Biol Chem; 1994 Oct; 269(41):25916-21. PubMed ID: 7929297
[TBL] [Abstract][Full Text] [Related]
15. Complex formation between deoxyhypusine synthase and its protein substrate, the eukaryotic translation initiation factor 5A (eIF5A) precursor.
Lee YB; Joe YA; Wolff EC; Dimitriadis EK; Park MH
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):273-81. PubMed ID: 10229683
[TBL] [Abstract][Full Text] [Related]
16. Post-translational modification of the protein-synthesis initiation factor eIF-4D by spermidine in rat hepatoma cells.
Gerner EW; Mamont PS; Bernhardt A; Siat M
Biochem J; 1986 Oct; 239(2):379-86. PubMed ID: 3101665
[TBL] [Abstract][Full Text] [Related]
17. Effects of inhibitors of deoxyhypusine synthase on the differentiation of mouse neuroblastoma and erythroleukemia cells.
Chen ZP; Yan YP; Ding QJ; Knapp S; Potenza JA; Schugar HJ; Chen KY
Cancer Lett; 1996 Aug; 105(2):233-9. PubMed ID: 8697449
[TBL] [Abstract][Full Text] [Related]
18. Enzyme-substrate intermediate formation at lysine 329 of human deoxyhypusine synthase.
Wolff EC; Folk JE; Park MH
J Biol Chem; 1997 Jun; 272(25):15865-71. PubMed ID: 9188485
[TBL] [Abstract][Full Text] [Related]
19. Targeting the polyamine-hypusine circuit for the prevention and treatment of cancer.
Nakanishi S; Cleveland JL
Amino Acids; 2016 Oct; 48(10):2353-62. PubMed ID: 27357307
[TBL] [Abstract][Full Text] [Related]
20. Post-translational formation of hypusine in eIF5A: implications in human neurodevelopment.
Park MH; Kar RK; Banka S; Ziegler A; Chung WK
Amino Acids; 2022 Apr; 54(4):485-499. PubMed ID: 34273022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
